Status:

COMPLETED

Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients

Lead Sponsor:

Beth Israel Medical Center

Conditions:

Colorectal Cancer (CRC)

Eligibility:

All Genders

Phase:

NA

Brief Summary

Given the apparent effect of 18 metabolic equivalent task-hours of activity/week in improving disease free survival in patients with treated stage 3 colon cancer and the survival benefit of exercise d...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients with histological confirmation of stage 2 or stage 3 colorectal cancer.
  • Ability to sign written informed consent.
  • WHO performance status of 2 or better.
  • No evidence of recurrent disease or death prior to second questionnaire.
  • Patients with declining physical activity within 90 days of second physical activity assessment will be excluded.
  • There are no exclusion criteria

Exclusion

    Key Trial Info

    Start Date :

    April 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2010

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT00977613

    Start Date

    April 1 2007

    End Date

    May 1 2010

    Last Update

    March 3 2011

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Beth Israel Medical Center - Philipps Ambulatory Care Center

    New York, New York, United States, 10003

    2

    St. Luke's Roosevelt Hospital Center

    New York, New York, United States, 10019